Sandoz Specialty Summit 2024: Advancing patient access to quality treatments in Vietnam
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Partnership reinforces commitment of Sandoz to reducing cancer burden in Vietnam Second such partnership with a Vietnamese hospital to improve…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Partnership reinforces commitment of Sandoz to reducing cancer burden in Vietnam Second such partnership with a Vietnamese hospital to improve…